Taiwanese start-up Aidmics is hoping to cash in on the $US40 billion global human fertility market with an iPad-compatible gadget it calls iSperm.
Infertility Options
Taiwanese start-up Aidmics is hoping to cash in on the $US40 billion global human fertility market with an iPad-compatible gadget it calls iSperm.